Type 1 or Type 2 T Cell Responses

2002 ◽  
Vol 76 (13) ◽  
pp. 6652-6659 ◽  
Author(s):  
Shin Sasaki ◽  
Rama Rao Amara ◽  
Wen-Shuz Yeow ◽  
Paula M. Pitha ◽  
Harriet L. Robinson

ABSTRACT Interferon regulatory factor 1 (IRF-1), IRF-3, and IRF-7 have been tested as genetic adjuvants for influenza virus hemagglutinin (HA) and nucleoprotein vaccine DNAs. Cotransfection of HA with IRF-3 and IRF-7 increased CD4 T-cell responses by 2- to 4-fold and CD8 T-cell responses by more than 10-fold. Following intramuscular deliveries of DNA, both CD4 and CD8 T cells were biased towards type 1 immune responses and the production of gamma interferon. Following gene gun bombardments of DNA, both were biased towards type 2 immune responses and the production of interleukin-4. The biases of the T-cell responses towards type 1 or type 2 were stronger for immunizations with IRF-3 as an adjuvant than for immunizations with IRF-7 as an adjuvant. Moderate adjuvant effects for antibody were observed. The isotypes of the antibody responses reflected the method of DNA delivery; intramuscular deliveries of DNA predominantly raised immunoglobulin G2a (IgG2a), whereas gene gun deliveries of DNA predominantly raised IgG1. These biases were enhanced by the codelivered IRFs. Overall, under the conditions of our experiments, IRF-3 had good activity for T cells, IRF-7 had good activity for both antibody and T cells, and IRF-1 had good activity for antibody.


2005 ◽  
Vol 35 (5) ◽  
pp. 1445-1453 ◽  
Author(s):  
Geraldine?M.?A. Gillespie ◽  
Susana Pinheiro ◽  
Mohammad Sayeid-Al-Jamee ◽  
Abraham Alabi ◽  
Steve Kaye ◽  
...  

Nutrition ◽  
2000 ◽  
Vol 16 (6) ◽  
pp. 442-446 ◽  
Author(s):  
Harumi Jyonouchi ◽  
Sining Sun ◽  
Toichi Abiru ◽  
Timothy Winship ◽  
Matthew J Kuchan

Diabetes ◽  
2008 ◽  
Vol 57 (5) ◽  
pp. 1312-1320 ◽  
Author(s):  
E. Martinuzzi ◽  
G. Novelli ◽  
M. Scotto ◽  
P. Blancou ◽  
J.-M. Bach ◽  
...  

2003 ◽  
Vol 77 (3) ◽  
pp. 2081-2092 ◽  
Author(s):  
M. M. Addo ◽  
X. G. Yu ◽  
A. Rathod ◽  
D. Cohen ◽  
R. L. Eldridge ◽  
...  

ABSTRACT Cellular immune responses play a critical role in the control of human immunodeficiency virus type 1 (HIV-1); however, the breadth of these responses at the single-epitope level has not been comprehensively assessed. We therefore screened peripheral blood mononuclear cells (PBMC) from 57 individuals at different stages of HIV-1 infection for virus-specific T-cell responses using a matrix of 504 overlapping peptides spanning all expressed HIV-1 proteins in a gamma interferon-enzyme-linked immunospot (Elispot) assay. HIV-1-specific T-cell responses were detectable in all study subjects, with a median of 14 individual epitopic regions targeted per person (range, 2 to 42), and all 14 HIV-1 protein subunits were recognized. HIV-1 p24-Gag and Nef contained the highest epitope density and were also the most frequently recognized HIV-1 proteins. The total magnitude of the HIV-1-specific response ranged from 280 to 25,860 spot-forming cells (SFC)/106 PBMC (median, 4,245) among all study participants. However, the number of epitopic regions targeted, the protein subunits recognized, and the total magnitude of HIV-1-specific responses varied significantly among the tested individuals, with the strongest and broadest responses detectable in individuals with untreated chronic HIV-1 infection. Neither the breadth nor the magnitude of the total HIV-1-specific CD8+-T-cell responses correlated with plasma viral load. We conclude that a peptide matrix-based Elispot assay allows for rapid, sensitive, specific, and efficient assessment of cellular immune responses directed against the entire expressed HIV-1 genome. These data also suggest that the impact of T-cell responses on control of viral replication cannot be explained by the mere quantification of the magnitude and breadth of the CD8+-T-cell response, even if a comprehensive pan-genome screening approach is applied.


Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 109-OR
Author(s):  
ANGELA M. MITCHELL ◽  
AIMON ALKANANI ◽  
KRISTEN MCDANIEL ◽  
LAURA PYLE ◽  
KATHLEEN WAUGH ◽  
...  

Diabetologia ◽  
2010 ◽  
Vol 53 (7) ◽  
pp. 1451-1460 ◽  
Author(s):  
L. G. Petrich de Marquesini ◽  
J. Fu ◽  
K. J. Connor ◽  
A. J. Bishop ◽  
N. E. McLintock ◽  
...  

2010 ◽  
Vol 7 (5) ◽  
pp. 355-360 ◽  
Author(s):  
Naihong Zhang ◽  
Zhaoe Wang ◽  
Xiaofei Tang ◽  
Haiping Wang ◽  
Hongzhao Li ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document